Jan 12 (Reuters) - Integral Diagnostics Ltd IDX.AX :
* CAPITAL EXPENDITURE FOR FULL YEAR IS FORECAST AT $17M
* EXPECTS ACHIEVEMENT OF FULL YEAR NORMALISED NPAT GROWTH OF AROUND 20% (BEFORE TAKEOVER RESPONSE COSTS AND TRANSACTION COSTS)
Jan 12 (Reuters) - Integral Diagnostics Ltd IDX.AX :
* CAPITAL EXPENDITURE FOR FULL YEAR IS FORECAST AT $17M
* EXPECTS ACHIEVEMENT OF FULL YEAR NORMALISED NPAT GROWTH OF AROUND 20% (BEFORE TAKEOVER RESPONSE COSTS AND TRANSACTION COSTS)